Comparison Overview
Novoheart
Novoheart
6 Tide St, 2nd Floor, Boston, 02210, US
Last Update: 28/12/2025
Novoheart, a subsidiary wholly-owned by Medera (www.linkedin.com/company/medera-biopharmaceutical), is responsible for Disease Modelling & Drug Discovery using our proprietary award-winning mini-Heart Technology, which offers a range of bioengineered human heart constru...
Gilead Sciences
333 Lakeside Drive, Foster City, 94404, US
Last Update: 20/05/2026
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and ...
Compliance Ranges Comparison
Novoheart
Gilead Sciences
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Novoheart in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Gilead Sciences in 2026.
Incident History - Novoheart (X = Date, Y = Severity)
Novoheart cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Gilead Sciences (X = Date, Y = Severity)
Gilead Sciences cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Novoheart
Gilead Sciences
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.